Pharma & Biotech Market Research

In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech

Stay up-to-date with new products added to this category

Results 401 - 500 of 5395 go to 1st page

first

previous 1 2 3 4 5 6 7 8 9 10 11 next

last

Title	Date	Price
Medinova Ltd.-Company Report	Sep 2009	£460
Mediolanum farmaceutici S.p.A-Company Report	Sep 2009	£460
MediQuest Therapeutics, Inc.-Company Report	Sep 2009	£460
Medison Pharma Ltd.-Company Report	Sep 2009	£460
Medisyn Technologies, Inc.-Company Report	Sep 2009	£460
Medinox, Inc.-Company Report	Sep 2009	£460
Medimport S.A. de C.V-Company Report	Sep 2009	£460
Medico Remedies Pvt. Ltd.-Company Report	Sep 2009	£460
Medigen Biotechnology Corp.-Company Report	Sep 2009	£460
MediGene AG-Company Report	Sep 2009	£460
Mediline Ltd.-Company Report	Sep 2009	£460
Medivir AB-Company Report	Sep 2009	£460
MEDLEY PHARMACEUTICALS LTD.-Company Report	Sep 2009	£460
Mepha AG-Company Report	Sep 2009	£455
Mentor Corporation-Company Report	Sep 2009	£455
Mercian Corporation-Company Report	Sep 2009	£455
Merck Frosst Canada Ltd.-Company Report	Sep 2009	£455
Merck Serono S.A.-Company Report	Sep 2009	£455
Menarini Group-Company Report	Sep 2009	£455
Memgen, LLC-Company Report	Sep 2009	£460
Medopharm-Company Report	Sep 2009	£460
Medreich Plc-Company Report	Sep 2009	£460
Meiji Seika Kaisha, Ltd.-Company Report	Sep 2009	£460
Melior Discovery, Inc.-Company Report	Sep 2009	£460
Medico Labs Inc-Company Report	Sep 2009	£460
Medical Therapies Ltd-Company Report	Sep 2009	£460
Mapra Laboratories Pvt. Ltd.-Company Report	Sep 2009	£460
Maneesh Pharmaceuticals Private Ltd-Company Report	Sep 2009	£455
Marillion Pharmaceuticals, Inc-Company Report	Sep 2009	£460
MarinEx Pharmaceuticals Pte Ltd-Company Report	Sep 2009	£460
Maruishi Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£460
Mallinckrodt Inc.-Company Report	Sep 2009	£455
Maiden Pharmaceuticals Ltd.-Company Report	Sep 2009	£455
M et P Pharma AG (formerly Mattern Pharmaceuticals AG)-Company Report	Sep 2009	£455
Maas BiolAB-Company Report	Sep 2009	£455
MACLEODS PHARMACEUTICALS LIMITED-Company Report	Sep 2009	£455
MacroGenics Inc.-Company Report	Sep 2009	£455
MAT Biopharma-Company Report	Sep 2009	£460
MaxoCore Pharmaceuticals Inc-Company Report	Sep 2009	£460
medac GmbH-Company Report	Sep 2009	£460
Medek Ltd-Company Report	Sep 2009	£460
Medestea Internazionale S.p.A.-Company Report	Sep 2009	£460
MedExGen Inc.-Company Report	Sep 2009	£460
Meda AB-Company Report	Sep 2009	£460
Med Gen Inc.-Company Report	Sep 2009	£460
May & Baker Nigeria Plc-Company Report	Sep 2009	£460
MDC Pharmaceuticals Pvt Ltd.-Company Report	Sep 2009	£460
MEABCO A/S-Company Report	Sep 2009	£460
Mebiopharm Co., Ltd.-Company Report	Sep 2009	£460
Merck KGaA-Company Report	Sep 2009	£455
Merckle Group-Company Report	Sep 2009	£455
Morepen Laboratories Limited-Company Report	Sep 2009	£455
Moraceae Pharmaceuticals Pvt Ltd.-Company Report	Sep 2009	£455
MorphoSys AG-Company Report	Sep 2009	£455
Morria Biopharmaceuticals Plc.-Company Report	Sep 2009	£455
MOVETIS NV-Company Report	Sep 2009	£455
MonoSol RX-Company Report	Sep 2009	£455
mondoBIOTECH group-Company Report	Sep 2009	£455
Molecular Design International (MDI)-Company Report	Sep 2009	£455
MolMed S.p.A.-Company Report	Sep 2009	£455
Molteni Farmaceutici-Company Report	Sep 2009	£455
Molteni Dental-Company Report	Sep 2009	£455
Mpex Pharmaceuticals-Company Report	Sep 2009	£455
multimmune GmbH-Company Report	Sep 2009	£455
MyungMoon Pharm Co. Ltd-Company Report	Sep 2009	£455
NanoBio Corporation-Company Report	Sep 2009	£455
NanoDel Technologies GmbH-Company Report	Sep 2009	£455
Nanotherapeutics, Inc.-Company Report	Sep 2009	£455
Nanjing Lifenergy R&D Co., Ltd.-Company Report	Sep 2009	£455
Mystic Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
MultiPharma Sweden AB-Company Report	Sep 2009	£455
Mundipharma International Limited-Company Report	Sep 2009	£455
Mundipharma K.K.-Company Report	Sep 2009	£455
MycoLogics, Inc-Company Report	Sep 2009	£455
moksha8 Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Mochida Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Meyer Pharmaceuticals, LLC-Company Report	Sep 2009	£455
Metabolic Solutions Development Co.-Company Report	Sep 2009	£455
MicroBiotiX, Inc-Company Report	Sep 2009	£455
Microlabs Ltd.-Company Report	Sep 2009	£455
MIKA Pharma GmbH-Company Report	Sep 2009	£455
Metabolex, Inc.-Company Report	Sep 2009	£455
Mesoblast Limited-Company Report	Sep 2009	£455
MerLion Pharmaceuticals Pte. Ltd-Company Report	Sep 2009	£455
Merrimack Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Merrion Pharmaceuticals, Ltd.-Company Report	Sep 2009	£455
Merz Pharma GmbH & Co. KGaA-Company Report	Sep 2009	£455
Mikasa Seiyaku Co., Ltd.-Company Report	Sep 2009	£455
Milan Laboratories (India) Private Limited-Company Report	Sep 2009	£455
Mission Pharmacal Company-Company Report	Sep 2009	£455
Mitsubishi Tanabe Pharma Corporation-Company Report	Sep 2009	£455
MN Pharmaceuticals-Company Report	Sep 2009	£455
Moberg Derma AB-Company Report	Sep 2009	£455
Mission Pharmaceuticals Ltd.-Company Report	Sep 2009	£455
Mirna Therapeutics Inc.-Company Report	Sep 2009	£455
Millennium Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Minapharm Pharmaceuticals-Company Report	Sep 2009	£455
Minerva Pharmaceutical S.A.-Company Report	Sep 2009	£455
Mipharm SpA-Company Report	Sep 2009	£455
Napo Pharmaceuticals Inc.-Company Report	Sep 2009	£455